Latest Market Expansion News

BCAL Diagnostics has reported strong early commercial uptake of its BREASTEST plus non-invasive breast cancer diagnostic test, alongside a new partnership with Cancer Care Associates to expand market reach.

DroneShield Limited has reported a record-breaking second quarter with revenues surging 480% year-on-year, underpinned by a robust $176 million in committed sales and a $2.3 billion pipeline. The company is aggressively expanding manufacturing and investing in next-generation counter-drone technologies to meet soaring global demand.

Spectur Limited reports a positive operating cash flow for Q4 FY25, driven by revenue growth and cost-cutting, alongside strategic investments in cloud and connectivity technology.

PolyNovo Limited reports a robust FY25 with nearly 29% sales growth, a significant cash increase to A$33.5 million, and expanding global market presence. The company’s strategic investments and product innovations signal strong momentum ahead.

Spenda Limited has reported a record-breaking FY25 with cash receipts soaring 114% to $11.5 million and launched its APG Pay platform backed by a $50 million funding commitment. The company also trimmed operating costs by 39%, setting a leaner foundation for FY26 growth.

Osteopore Limited reports a three-fold increase in craniofacial implant sales within a year of signing an exclusive distribution deal with Zimmer Biomet, signaling strong early traction across key global markets.

Biome Australia Limited has delivered record sales revenue in Q4 FY25 alongside positive EBITDA, setting the stage for its first full-year net profit. Strategic product launches and international expansion underpin its strong growth trajectory.

Algorae Pharmaceuticals has advanced its AI-driven drug discovery platform into preclinical validation through a strategic collaboration with the Peter MacCallum Cancer Centre, while progressing its therapeutic pipeline and commercial leadership.

De.mem Limited has reported its second highest quarterly cash receipts ever, alongside a fourth consecutive quarter of positive operating cash flow, positioning the company for a record full-year 2025 performance.

Bioxyne Limited has reported record revenue and cash flow for FY25, driven by robust growth in the Australian medical cannabis market and strategic advances into Europe and the UK.

Murray Cod Australia reports a near tripling of biomass and strong sales growth in Q4 FY25, while advancing key certifications and expanding market reach.

Adveritas Limited reports a robust 62% increase in annualised recurring revenue to $10.47 million and a record doubling of full-year cash receipts, backed by a strategic $8.5 million institutional placement to accelerate growth in the US and new verticals.